8 Best Genomics Stocks to Buy According to Analysts
On June 8, 2026, Google DeepMind, Google.org, and the Wellcome Sanger Institute announced a five-year artificial intelligence collaboration for genomics.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 3,207,366 | $641,441,126 | -19% | 3.66% |
| 2. | Coatue Management Philippe Laffont | 2,541,842 | $508,342,981 | -4% | 1.75% |
| 3. | Castle Hook Partners Josh Donfeld And David Rogers | 2,529,810 | $505,936,702 | +17% | 2.16% |
| 4. | AQR Capital Management Cliff Asness | 2,273,991 | $442,564,045 | -13% | 0.2% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,191,732 | $238,334,483 | +1% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | $562,054.51 | 420,000 | 2022-05-12 | Filing | |
| $28.81 | 159,783 | $4,603,348.23 | 400,989 | 2022-05-12 | Filing | |
| $28.09 | 41,026 | $1,152,358.80 | 241,026 | 2022-05-12 | Filing | |
| $33.49 | 40,695 | $1,362,798.23 | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | $2,799,982.51 | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $218.82 | 116 | $25,382.54 | 6,183 | 2026-06-05 | Filing | |
| $218.11 | 3,174 | $692,276.06 | 6,299 | 2026-06-05 | Filing | |
| $217.30 | 4,694 | $1,020,023.10 | 9,473 | 2026-06-05 | Filing | |
| $216.06 | 3,016 | $651,646.31 | 14,167 | 2026-06-05 | Filing | |
| $226.97 | 3,409 | $773,740.39 | 108,743 | 2026-06-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,386,667 | $2,501,165,314 | 0.16% | |
| 2. | 10,677,338 | $2,135,360,953 | 0.04% | |
| 3. | 6,008,496 | $1,201,639,115 | 0.02% | |
| 4. | 5,644,695 | $1,128,882,553 | 0.05% | |
| 5. | 4,768,593 | $953,670,913 | 0.18% |
News See All
Top 10 Stock Picks of 10 Famous Billionaires
Smart money is back in the spotlight as hedge funds attract strong inflows and post solid returns.
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller
What sets billionaire Stanley Druckenmiller apart from other Wall Street giants is his frankness, humility, and openness to learn.
Natera, Inc. (NASDAQ:NTRA) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to Natera, Inc.'s First Quarter 2026 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Druckenmiller and Jim Cramer Like These Stocks
Stanley Druckenmiller and Jim Cramer are two of the closely followed voices in financial markets. Though sometimes their stock preferences differ, they always draw widespread investor attention.
Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential
Tom Steyer, the billionaire investor and founder of Farallon Capital, has undergone a profound evolution from a pioneer of absolute-return hedge fund strategies to a leading architect of climate capitalism...
Should You Be Bullish on Natera (NTRA)?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Billionaire Stan Druckenmiller's 10 Small and Mid-Cap Stock Picks with Huge Upside Potential
Stanley Druckenmiller, the founder of New York-based Duquesne Family Office, oversees a 13F portfolio at his hedge fund that was worth close to $4.5 billion at the end of the fourth quarter of 2025.
10 Best Diagnostics and Research Stocks to Buy According to Analysts
The diagnostics and research sector holds a crucial position in the healthcare ecosystem, thus attracting investor interest.
Signatera Oncology Test Drives Natera’s (NTRA) Growth
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here...
Hedge Fund Resource Center